Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Allergan | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Allergan

Botox sales up 15% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Allergan

1Q Revenues: $1.4 billion (+8%)

1Q Earnings: $14.4 million (earnings were $230.3 million 1Q12)

Comments: Specialty pharmaceutical sales increased 8% to $1.2 billion. Botox/Neuromodulator sales were up 15% to $457.9 million. Eye Care Pharmaceutical sales were up 3% to $668.6 million. Medical devices sales increased 10% to $200.7 million. Facial Aesthetics sales were up 33% to $111.1 million. Earnings reflect loss on the sale of discontinued operations of $259.0 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters